Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Aurinia Pharmaceuticals Inc Stock Price (Quote) NASDAQ:AUPH
$29.84 ( 6.57% ) Monday, 25th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $17.65 | $30.95 | Monday, 25th Oct 2021 AUPH stock ended at $29.84. This is 6.57% more than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 5.81% from a day low at $29.25 to a day high of $30.95. |
| 90 days | $10.85 | $30.95 | |
| 52 weeks | $9.72 | $30.95 |
Historical Aurinia Pharmaceuticals Inc prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-25 | $30.14 | $30.95 | $29.25 | $29.84 | 15 912 145 |
| 2021-10-22 | $21.80 | $28.00 | $21.66 | $28.00 | 6 110 528 |
| 2021-10-21 | $20.69 | $22.39 | $20.69 | $22.09 | 3 750 366 |
| 2021-10-20 | $20.01 | $20.96 | $19.78 | $20.65 | 3 946 794 |
| 2021-10-19 | $19.81 | $20.69 | $19.81 | $19.93 | 1 614 882 |
| 2021-10-18 | $20.54 | $20.67 | $19.61 | $19.70 | 2 121 205 |
| 2021-10-15 | $21.07 | $21.24 | $20.52 | $20.57 | 1 552 174 |
| 2021-10-14 | $21.25 | $21.53 | $20.80 | $21.04 | 1 398 015 |
| 2021-10-13 | $20.81 | $21.56 | $20.66 | $21.25 | 1 966 607 |
| 2021-10-12 | $20.58 | $21.75 | $20.36 | $20.69 | 3 240 843 |
| 2021-10-11 | $19.26 | $20.98 | $18.33 | $20.48 | 4 850 134 |
| 2021-10-08 | $19.68 | $20.42 | $19.25 | $19.33 | 1 806 384 |
| 2021-10-07 | $19.20 | $20.30 | $18.87 | $19.84 | 2 631 387 |
| 2021-10-06 | $20.90 | $21.30 | $17.65 | $18.85 | 7 740 192 |
| 2021-10-05 | $21.26 | $22.00 | $21.00 | $21.28 | 2 133 048 |
| 2021-10-04 | $21.75 | $22.64 | $20.95 | $21.09 | 2 886 718 |
| 2021-10-01 | $22.09 | $22.29 | $20.81 | $21.81 | 3 534 905 |
| 2021-09-30 | $22.99 | $23.17 | $21.89 | $22.13 | 2 550 715 |
| 2021-09-29 | $22.69 | $23.89 | $22.69 | $22.99 | 3 899 006 |
| 2021-09-28 | $23.40 | $23.48 | $21.88 | $22.20 | 4 601 029 |
| 2021-09-27 | $23.36 | $23.79 | $22.95 | $23.55 | 1 886 372 |
| 2021-09-24 | $23.65 | $24.00 | $22.79 | $23.24 | 2 697 259 |
| 2021-09-23 | $23.46 | $23.95 | $22.88 | $23.51 | 3 043 646 |
| 2021-09-22 | $23.10 | $23.99 | $22.36 | $23.43 | 4 598 922 |
| 2021-09-21 | $21.01 | $24.18 | $20.79 | $22.64 | 7 612 123 |
| 2021-09-20 | $19.99 | $21.80 | $19.86 | $20.91 | 4 812 028 |
| 2021-09-17 | $19.31 | $21.27 | $19.25 | $21.00 | 5 899 491 |
| 2021-09-16 | $20.62 | $20.71 | $18.74 | $19.38 | 4 476 418 |
| 2021-09-15 | $21.17 | $21.40 | $20.26 | $20.79 | 6 279 561 |
| 2021-09-14 | $20.92 | $21.86 | $20.72 | $21.50 | 5 361 481 |
| 2021-09-13 | $19.68 | $21.73 | $19.07 | $20.93 | 6 885 566 |
| 2021-09-10 | $19.46 | $19.99 | $18.55 | $19.89 | 3 992 198 |
| 2021-09-09 | $19.00 | $19.44 | $18.86 | $19.35 | 3 340 383 |
| 2021-09-08 | $18.32 | $19.51 | $17.94 | $19.46 | 4 822 867 |
| 2021-09-07 | $17.53 | $18.70 | $17.53 | $18.15 | 4 826 507 |
| 2021-09-03 | $17.50 | $17.78 | $17.20 | $17.54 | 1 638 244 |
| 2021-09-02 | $16.90 | $17.57 | $16.73 | $17.55 | 2 277 377 |
| 2021-09-01 | $16.39 | $17.58 | $16.36 | $16.98 | 2 278 314 |
| 2021-08-31 | $16.96 | $17.07 | $16.14 | $16.28 | 2 915 618 |
| 2021-08-30 | $17.80 | $18.12 | $16.53 | $17.02 | 3 926 731 |
| 2021-08-27 | $18.12 | $18.80 | $17.26 | $17.70 | 5 511 567 |
| 2021-08-26 | $16.26 | $18.07 | $15.29 | $17.93 | 9 145 901 |
| 2021-08-25 | $15.14 | $16.97 | $15.11 | $16.44 | 6 487 907 |
| 2021-08-24 | $14.46 | $15.36 | $14.00 | $15.30 | 4 292 742 |
| 2021-08-23 | $14.14 | $14.47 | $13.83 | $14.33 | 2 086 650 |
| 2021-08-20 | $12.97 | $14.01 | $12.96 | $13.64 | 1 959 939 |
| 2021-08-19 | $12.97 | $13.76 | $12.88 | $13.00 | 2 265 252 |
| 2021-08-18 | $13.22 | $13.49 | $12.71 | $13.06 | 2 026 196 |
| 2021-08-17 | $13.27 | $13.88 | $12.62 | $13.04 | 5 341 126 |
| 2021-08-16 | $15.15 | $15.15 | $14.25 | $14.46 | 2 059 795 |
Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada. The companys lead drug candidate is Voclosporin, a calcineurin inhibitor, which is in Phase IIb clinical trial for the treatment of lupus nephritis. It has a collaboration agreement with Paladin Labs Inc. to maintain the patent portfolio for Voclosporin in Canada, South Africa, and Israe... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
